Summit Therapeutics Inc. — Form D

Summit Therapeutics Inc. of Miami, FL, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-02. The offering totals $47.4M, of which $47.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Robert W DugganDirectorAbingdon, X0
Glyn EdwardsDirectorAbingdon, X0
Manmeet W SoniDirectorAbingdon, X0
Ventzislav W StefanovDirectorAbingdon, X0
Elaine W StrackerDirectorAbingdon, X0
Glyn EdwardsExecutive OfficerAbingdon, X0
Daniel W ElgerExecutive OfficerAbingdon, X0
David RoblinExecutive OfficerMiami Beach, FL
Jeff HuberDirectorSan Francisco, CA
Robert DugganDirectorGrand Cayman, E9
Robert DugganExecutive OfficerGrand Cayman, E9
Mostafa RonaghiDirectorFoster City, CA
Manmeet SoniDirectorMiami, FL
Manmeet SoniExecutive OfficerMiami, FL
Mahkam ZanganehDirectorMiami, FL
Mahkam ZanganehExecutive OfficerMiami, FL
Alessandra CesanoDirectorMiami, FL
Kenneth ClarkDirectorMiami, FL
Yu XiaDirectorMiami, FL
Robert BoothDirectorMiami, FL
Ujwala MahatmeDirectorMiami, FL
Leopoldo ZambelettiDirectorCOVINA, CA
Jim MellonDirectorLauderhill, FL
David WurzerDirectorMystic, CT
Rainer ErdtmannDirectorEl Cerrito, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2024-09-26D$235.0M$235.0M
2024-06-18D$200.0M$200.0M
2020-11-23D$50.0M$50.0M
2019-01-18D$25.0M$25.0M
2014-03-04D$11.6M$11.6M

More